Elevated iron stores are associated with HIV disease severity and mortality among postpartum women in Zimbabwe

Public Health Nutrition

Volumn 12, Issue 9, 2009, Pages 1321-1329

  Rawat, R ^a   Humphrey, J H ^b,c   Ntozini, R ^b   Mutasa, K ^b   Iliff, P J ^b   Stoltzfus, R J ^d  

^a INTERNATIONAL FOOD POLICY RESEARCH INSTITUTE   (United States)

^b ZVITAMBO Study Team   (Zimbabwe)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Ferritin; HIV; Iron; Mortality; Viral load

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; OROSOMUCOID; TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; IRON STORAGE; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; PRIORITY JOURNAL; PUERPERIUM; VIRUS LOAD; ZIMBABWE;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HEMOGLOBINS; HIV INFECTIONS; HUMANS; IRON; KAPLAN-MEIERS ESTIMATE; NUTRITIONAL STATUS; POSTPARTUM PERIOD; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRACE ELEMENTS; VIRAL LOAD; ZIMBABWE;

EID: 69749117056     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S136898000800390X     Document Type: Article

References (38)

1. Sullivan P (2002) Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection. J Infect Dis 185, Suppl. 2, S138-S142. (Pubitemid 34499450)
2. Moore RD, Keruly JC & Chaisson RE (1998) Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 19, 2-33.
3. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ & Fawzi WW (2005) Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 40, 219-225. (Pubitemid 41395722)
4. Kreuzer KA & Rockstroh JK (1997) Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 75, 179-187. (Pubitemid 27525045)
5. Boelaert JR, Weinberg GA & Weinberg ED (1996) Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 5, 36-46.
6. Savarino A, Pescarmona GP & Boelaert JR (1999) Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 17, 279-287.
7. de Monye C, Karcher DS, Boelaert JR & Gordeuk VR (1999) Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS 13, 375-380.
8. Weinberg GA, Boelaert JR & Weinberg ED (2002) Iron and HIV infection. In Micronutrients and HIV Infection, pp. 135-157 [H Friis, editor]. Boca Raton, FL: CRC Press.
9. Humphrey JH, Hargrove JW, Malaba LC et al. (2006) HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 20, 1437-1446.
10. Doherty CP, Weaver LT & Prentice AM (2002) Micronutrient supplementation and infection: a double-edged sword? J Pediatr Gastroenterol Nutr 34, 346-352.
11. Clark TD & Semba RD (2001) Iron supplementation during human immunodeficiency virus infection: a double-edged sword? Med Hypotheses 57, 476-479.
12. Gordeuk VR, Delanghe JR, Langlois MR & Boelaert JR (2001) Iron status and the outcome of HIV infection: an overview. J Clin Virol 20, 111-115. (Pubitemid 32106864)
13. van den Broek NR, White SA & Neilson JP (1998) The relationship between asymptomatic human immunodeficiency virus infection and the prevalence and severity of anemia in pregnant Malawian women. Am J Trop Med Hyg 59, 1004-1007.
14. Semba RD, Kumwenda N, Hoover DR, Taha TE, Mtimavalye L, Broadhead R, Eisinger W, Miotti PG & Chiphangwi JD (2000) Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi. Eur J Clin Nutr 54, 872-877. (Pubitemid 32036941)
15. Friis H, Gomo E, Nyazema N, Ndhlovu P, Krarup H, Madsen PH & Michaelsen KF (2003) Iron, haptoglobin phenotype, and HIV-1 viral load: a cross-sectional study among pregnant Zimbabwean women. J Acquir Immune Defic Syndr 33, 74-81. (Pubitemid 36547244)
16. Olsen A, Mwaniki D, Krarup H & Friis H (2004) Low-dose iron supplementation does not increase HIV-1 load. J Acquir Immune Defic Syndr 36, 637-638. (Pubitemid 38544514)
17. Semba RD, Taha TE, Kumwenda N, Mtimavalye L, Broadhead R, Miotti PG & Chiphangwi JD (2001) Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi. Clin Infect Dis 32, 1496-1499. (Pubitemid 32424287)
18. Kupka R, Msamanga GI, Mugusi F, Petraro P, Hunter DJ & Fawzi WW (2007) Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression. J Nutr 137, 2317-2323. (Pubitemid 47529596)
19. Gordeuk VR, Onojobi G, Schneider MF et al. (2006) The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 91, 739-743. (Pubitemid 44014538)
20. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, Austin S, Jeffries D, Awasana AA, Whittlex AA & Prentice A (2007) Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 46, 498-507. (Pubitemid 350098703)
21. Humphrey JH, Iliff PJ, Marinda ET et al. (2006) Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 193, 860-871.
22. Zvandasara P, Hargrove JW, Ntozini R et al. (2006) Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation. J Acquir Immune Defic Syndr 43, 107-116. (Pubitemid 44306497)
23. Thurnham DI, Mburu AS, Mwaniki DL & De Wagt A (2005) Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc 64, 502-509.
24. Zimbabwean Central Statistical Office and Macro International Inc. (2001) Zimbabwe Demographic and Health Survey 1999, p. 151. Calverton, MD: Central Statistical Office (Zimbabwe) and Macro International Inc.
25. Filteau SM, Morris SS, Abbott RA, Tomkins AM, Kirkwood BR, Arthur P, Ross DA, Gyapong JO & Raynes JG (1993) Influence of morbidity on serum retinol of children in a community-based study in northern Ghana. Am J Clin Nutr 58, 192-197. (Pubitemid 23227891)
26. World Health Organization (2001) Iron Deficiency Anaemia. Assessment, Prevention, and Control. A Guide for Programme Managers. Geneva: WHO.
27. Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, Minkoff H & Hessol NA (2002) Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 113, 91-98. (Pubitemid 34804744)
28. Gibson RS (2005) Assessment of iron status. In Principles of Nutritional Assessment, 2nd ed., pp. 443-447. New York: Oxford University Press.
29. Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ & van Asbeck BS (2000) Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis 181, 484-490. (Pubitemid 30131814)
30. van Asbeck BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS & Marx JJ (2001) Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol 20, 141-147. (Pubitemid 32106870)
31. Costagliola DG, de Montalembert M, Lefrere JJ et al. (1994) Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients. Br J Haematol 87, 849-852.
32. Salhi Y, Costagliola D, Rebulla P, Dessi C, Karagiorga M, Lena-Russo D, de Montalembert M & Girot R (1998) Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. J Acquir Immune Defic Syndr Hum Retrovirol 18, 473-478. (Pubitemid 28387772)
33. Delanghe JR, Langlois MR, Boelaert JR et al. (1998) Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 12, 1027-1032.
34. McDermid JM & Prentice AM (2006) Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. Clin Sci (Lond) 110, 503-524.
35. Boelaert JR (1996) Iron and infection. Acta Clin Belg 51, 213-221.
36. Weinberg GA (1996) Iron overload as a mechanism for the lowered survival in AIDS patients receiving dapsone-iron protoxalate for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis 174, 241-242.
37. Brock J (1999) Iron and infection: molecular, physiological and clinical aspects. In Iron and Infection, pp. 289-325. Chichester: John Wiley & Sons.
38. Weiss G (2002) Iron and immunity: a double-edged sword. Eur J Clin Invest 32, Suppl.1, 70-78.